On 07 May 2019Unichem Laboratories Limited announced that it received tentative ANDA approval from USFDA for Unichem's Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets USP, 5 mg/120 mg (OTC) to market a generic version of Johnson and Johnson Consumer Inc's Zyrtec-D 12 Hour (Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride, 5mg/120 mg) Extended Tablets. These are indicated for antihistamine and nasal decongestant. The Product will be commercialized from Unichemls Goa Plant on receipt of final approval.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)